Get started
SIHUAN PHARMACEUTICAL HOLD GP LTDSIHUAN PHARMACEUTICAL HOLD GP LTDSIHUAN PHARMACEUTICAL HOLD GP LTD

SIHUAN PHARMACEUTICAL HOLD GP LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

460 chart


Full chart

460 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.72 B‬ HKD
Dividend yield (indicated)
2.92%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.00 HKD
Net income (FY)
‪−59.69 M‬ HKD
Revenue (FY)
‪2.06 B‬ HKD
Shares float
‪4.15 B‬
Beta (1Y)
1.06

Employees


Employees (FY)
‪2.87 K‬
Change (1Y)
−441 −13.31%
Revenue / Employee (1Y)
‪91.65 K‬ HKD
Net income / Employee (1Y)
‪−2.66 K‬ HKD

About SIHUAN PHARMACEUTICAL HOLD GP LTD


Sector
Health Technology
CEO
Wei Cheng Guo
Headquarters
Beijing
Website
sihuanpharm.com
Founded
2001
FIGI
BBG0016NP3X0
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

460 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 460 is 0.75 HKD — it hasn't changed in the past 24 hours. Watch SIHUAN PHARMACEUTICAL HOLD GP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SIHUAN PHARMACEUTICAL HOLD GP LTD stocks are traded under the ticker 460.
460 stock has risen by 1.41% compared to the previous week, the month change is a 7.46% rise, over the last year SIHUAN PHARMACEUTICAL HOLD GP LTD has showed a 8.70% increase.
460 reached its all-time high on Oct 17, 2014 with the price of 6.68 HKD, and its all-time low was 0.49 HKD and was reached on Feb 5, 2024. View more price dynamics on 460 chart.
See other stocks reaching their highest and lowest prices.
460 stock is 4.17% volatile and has beta coefficient of 1.06. Track SIHUAN PHARMACEUTICAL HOLD GP LTD stock price on the chart and check out the list of the most volatile stocks — is SIHUAN PHARMACEUTICAL HOLD GP LTD there?
Today SIHUAN PHARMACEUTICAL HOLD GP LTD has the market capitalization of ‪6.66 B‬, it has increased by 4.35% over the last week.
Yes, you can track SIHUAN PHARMACEUTICAL HOLD GP LTD financials in yearly and quarterly reports right on TradingView.
SIHUAN PHARMACEUTICAL HOLD GP LTD is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
460 net income for the last half-year is ‪−36.22 M‬ HKD, while the previous report showed ‪−4.72 M‬ HKD of net income which accounts for −666.65% change. Track more SIHUAN PHARMACEUTICAL HOLD GP LTD financial stats to get the full picture.
As of Nov 5, 2024, the company has ‪2.87 K‬ employees. See our rating of the largest employees — is SIHUAN PHARMACEUTICAL HOLD GP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIHUAN PHARMACEUTICAL HOLD GP LTD EBITDA is ‪−42.21 M‬ HKD, and current EBITDA margin is 1.27%. See more stats in SIHUAN PHARMACEUTICAL HOLD GP LTD financial statements.
Like other stocks, 460 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIHUAN PHARMACEUTICAL HOLD GP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIHUAN PHARMACEUTICAL HOLD GP LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIHUAN PHARMACEUTICAL HOLD GP LTD stock shows the buy signal. See more of SIHUAN PHARMACEUTICAL HOLD GP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.